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Abstract
INTRODUCTION: The results for the meta-analytical review, which contrasted laparoscopic or robotically assisted 
esophagectomy for cancer against open esophagectomy (OE), indicated feasibility and safety associated with the 
robotic method. 
AIM: The objective of this study is to review the current literature on MIE (Laparo-thoracoscopic and Robotic 
approach) and open approach and check the state-of-the-art of esophagectomy for cancer.
MATERIALS AND METHODS: The comparison of studies which contrasted laparoscopic or robotically assisted 
esophagectomy for cancer against open esophagectomy (OE). 
RESULTS: This review represented the largest sequence of mini-invasive esophagectomy (MIE) to date and the 
results appear to be comparable to those attained by the traditional open approach. MIE constitutes a safe procedure 
with a learning curve of around 36 cases.
CONCLUSION: The studies did not reveal variations in mortality and morbidity rate, conversion rate, intensive care 
unitstay, 1-month mortality, and post-operative complications between the mini-invasive esophagectomy cohort and 
OE cohort.
Introduction
Esophagectomy for cancer is a challenging 
and complex operation associated with a 
25%–50% rate of mortality and 2−8% mortality rate. 
Esophagectomy for cancer could be repaired using 
mini-invasive esophagectomy (MIE) laparoscopic or 
robotic. Research has shown that MIE led to reduced 
perioperative mortality, mortality, faster recovery, and 
shorter stay in hospital than open esophagectomy 
(OE). At present, mini-invasive method is becoming 
the standard for cancer. Surgical injury can be reduced 
using robotic methods in thoracic subjects and can lead 
to beneficial results in terms of anatomical recurrence 
and life quality. All subjects suffering from esophageal 
cancer can be given a minimally invasive surgical 
choice with the da Vinci Surgical System accessibility. 
All subjects suffering from esophageal cancer can be 
given a minimally invasive surgical choice with the 
da Vinci Surgical System accessibility. Although, only 
15% esophagectomy cases are carried out worldwide 
by making the use of traditional laparoscopic-
thoracoscopic or robotic techniques [1]. The objective 
of this study is to review the current literature on 
MIE (Laparo-thoracoscopic and Robotic approach) 
and open approach and check the state-of-the-art of 
esophagectomy for cancer.
Materials and Methods
Study selection
A systematic literature search from the 
GOOGLE SCHOLAR, EMBASE, MEDLINE, and 
PUBMED databases for studies published in the past 
20 years (that is, 1998–2018) was conducted. Several 
terms were used in the search, including “esophageal 
cancer,” “robotic,” “laparoscopic,” ”open,” “minimally-
invasive,” “esophagectomy,” “Ivor-Lewis,” and “three 
field esophagectomy.” Two investigators independently 
performed selection of manuscript based on these 
criteria.
Inclusion and exclusion criteria
The criteria for inclusion included: 
(1) Comparison of laparoscopic/robotically assisted 
esophagectomy (MIE) versus OE.
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(2) Studies featuring over 60 patients 
were taken into account. Intraoperative data, non-
comparative studies, low-quality studies, reviews, case 
reports, and abstracts that could not be obtained from 
the research published were left out.
Outcomes of interest
The following information was utilized for 
comparing patients on MIE to those undergoing 
OE: Pulmonary complications, significant morbidity, 
anastomotic leakage, hospital duration, mortality, time 
of operation, and loss of blood.
Outcomes
For what concern open approach, at 
moment various techniques exit for esophagectomy: 
Transthoracic esophagectomy (TTE) as Ivor-Lewis or 
McKeown and transhiatal esophagectomy (THE). While 
TTE provides extensive thoracic and mediastinal lymph 
nodes dissection, THE seems to have lower respiratory 
complication. Other scientific studies demonstrated 
similar 5 years results [2].
Babatunde et al. reported a review MIE versus 
OE among 4266 patients, 1308 (30.6%) of these 
underwent MIE. Subjects with MIE had considerably 
more lymph nodes assessed and shorter periods of 
hospital stay but similar resection margin positivity, 
readmission, and 30-day mortality. Survival for 
adenocarcinoma and squamous cell carcinoma both was 
comparable among the matched assembly at 3 years. 
They matched two groups using robotic-MIE versus 
Laparoscopic-MIE, and no discrepancies were found 
between R-MIE and L-MIE in lymph nodes harvested, 
positive resection margin, hospital stay period, 30 day 
readmission, or 30 day mortality. In 3 years survival, 
no significant differences were seen between R-MIE 
and L-MIE in subjects suffering from adenocarcinoma. 
Although, they noted “subjects suffering from squamous 
cell carcinoma who ‘R-MIE’ had statistically superior 
survival (84% vs. 56% at 2 years; p = 0.034).” They 
stated that “the minimally invasive procedures use for 
performing esophagectomy for esophageal cancer is 
correlated with perioperative results that are moderately 
enhanced with no compromise in survival” [3], [4].
One recent case-controlled study split 
154 patients on MIE (56) versus OE (98). In-hospital deaths 
and rates of morbidity did not differ considerably. Surgery 
period in MIE was longer and loss of blood was less. No 
disparity among the 2 categories was seen with respect 
to survival. The authors suggested that MIE is equivalent 
with the OE. In MIE, the major use of neoadjuvant therapy 
increases “the surgical morbidity risk” [5].
A separate open label research selected 
56 subjects randomly to the category of open 
esophagectomy and 59 to the group of minimally invasive 
esophagectomy. (Biere et al. 2012, The Lancet). In the 
open esophagectomy category, 16, i.e., 29% subjects 
had pulmonary infection in the first 2 weeks in comparison 
to five, i.e., 9% in the category of minimally invasive. 
Nineteen, i.e., 34% subjects in the open esophagectomy 
category had in-hospital pulmonary infection in 
comparison to seven, i.e., 12% subjects in the minimally 
invasive category. For in-hospital deaths, a subject died 
from anastomotic leakage in the open esophagectomy 
category and two died from aspiration and mediastinitis 
in the minimally invasive category following anastomotic 
leakage. The authors posited that MIE gives only proof 
for the short-term benefits [6].
Santos-Sousa et al. performed a case–control 
study including 79 patients, 65 cases (Group A: 24 
MIE – 13 totally MIE and 11 hybrid MIE; Group B: 
41 OE, including five cases of conversion from MIE). 
They noted that post-operative morbidity in MIE was 
37.5% versus in OE, it was 61%, with 16.7% and 
22% respiratory complications rates, correspondingly. 
The classification of post-operative mortality and 
post-operative morbidity in Clavin showed significant 
statistical variations. They reveal the effectiveness 
and potential enhancements of MIE’s post-operative 
mortality and morbidity [7].
Sihag et al. showed collection data from the 
Society of Thoracic Surgeons (STS) National Database 
for all resection executed between 2008 and 2011 for 
esophageal cancer.
With respect to pre-operative risk factors, both 
MIE and open groupings were comparable. MIE has 
been correlated to longer median procedural times, 
but a shorter median hospital stay duration. Subjects 
who had suffered from MIE had higher reoperation and 
empyema rates. A higher infection rate with wounds, 
ileus, post-operative transfusion was contributed by 
open technique. They concluded that “Early results 
from the STS National Database indicate that MIE is 
safe, with comparable rates of morbidity and mortality 
as open technique” [8].
In 2015, Guo et al. performed a meta-analysis 
of 13 findings involving an overall 1549 patients suffering 
from resectable esophageal cancer and discovered 
that MIE does not affect the effect of long-term curing. 
In fact, following the MIE the 2-year rate of survival 
was higher than that preceding OE. The anastomosis 
leakage incidence was comparable in both categories, 
while the group of OE had greater operative loss of 
blood [9].
Robotic aided esophagectomy has been 
gaining acceptance in larger scale and broader 
consensus after this first study conducted [10]. Better 
maneuverability of “endo wrist” equipment, magnified 
3D vision, tremor filtration, motion scaling, and a more 
relaxed surgical position could be of much more help 
in such a complex surgical process than conventional 
MIE particularly in thoracoscopic phase. The Endo 
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Wrist equipment’s utilization, the motion scaling, tremor 
filtration and the finer high-definition 3D vision make 
it possible and smoother to achieve a hand-sewn 
intrathoracic anastomosis.
In 2007, revealed the first series of robotic 
esophagectomy demonstrated a long operative time for 
totally robotic esophagectomy, a rate of morbidity was 
29% and a rate of disease-free survival was 87% [11], 
[12].
In 2012, stated a prospective study of 49 robotic-
assisted McKeown esophagectomy demonstrating 
46% total major morbidity with a reduced respiratory 
problem from 57 % with respect to OE to 33% in robotic 
aided esophagectomy [13].
Weksler et al., in 2012, showed similar morbidity, 
mortality, length of stay (LFN), and leflunomide between 
robotic and laparoscopic esophagectomy [12].
In 2017, Okusanya et al. reported 25 RAMIE 
obtaining R0 in 96% cases and similar 30-day mortality, 
leakage, LFN and conversion rate to conventional 
laparoscopic technique [14], [15].
Limitations
There are numerous limitations in the review. 
First, the review focused solely on English literature. 
Second, the selection and search of studies were 
conducted by one author. Third, there was no balance 
in the studies concerning the exactly lymph nodes 
retrieved, technique, conversion rate, outcomes in 
5 years.
Conclusion
This review represented the largest sequence 
of MIE to date and the results appear to be comparable 
to those attained by the traditional open approach. 
MIE constitutes a safe procedure with a learning 
curve of around 36 cases. With more experience, the 
complications, hospital, and operation time reduce 
without undermining the principles of surgery. Future 
studies with large patient cohorts alongside prospective 
randomized controlled trials are required to prove 
the durable nature of the procedure as opposed 
to the existing laparoscopic approach. In addition, 
several concerns should be addressed to establish 
the viability, safety, and clinical outcomes of robotic 
for elective surgical treatments of esophageal cancer 
in the future. They include for criteria of using robot, 
standard technique. MIE is achieving preponderating 
acceptance. The EndoWrist equipments’ use, the more 
in-depth high-definition standard 3D vision, tremor 
filtration, and motion scaling render some benefits. 
In 2016, Haverkamp et al. carried out an assessment 
on 1118 members of the International Society for 
Diseases of Esophagus, the World Organization for 
Specialized Studies on Diseases of the Esophagus, 
and the International Gastric Cancer Association. In 
43% cases particularly in high volume centers, the 
minimally invasive transthoracic method was adopted. 
In the systematic review, it can be concluded that the 
two techniques produce comparable results in terms 
of complications and reoperation rate save for reduced 
time robotic technique. Nevertheless, there is need 
for further studies to prove the efficacy and long-
term safety of certain forms of MIE before its routine 
implementation.
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